date:Apr 04, 2019
tion Centre, based in Singapore, that has already developed a strong expertise in research and development (RD) and in pharma CTS. It further intensifies Roquettes technical capabilities in Asia, which currently rely on CTS centres in Shanghai, China; Mumbai, India; Tokyo, Japan and Singapore.
This move will also allow the company to further develop strategic partnerships with customers, universities and research institutions in the region, and will also help in tailoring solutions to the dist